Home > Analytics > JUBILANT PHARMOVA

JUBILANT PHARMOVA
Intrinsic Value | Fundamental Analysis

BOM : 530019     NSE : JUBLPHARMA    
LT :  
    Long Term Analysis
Fundamentals : Average
Valuation : Good [Stock is Cheap]
Debt : High
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Downward
Pledged Shares : NA
Feb 08,2023
Price(EOD): ₹ 328.55
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Pharmaceuticals & Drugs
MCap: ₹ 5,233.80 Cr
Value of ₹ 1 Lac invested in JUBILANT PHARMOVA
on Feb 08,2018 (price: ₹ 968.40)

₹ 1 L

₹ 0.34 L

1W : -5.6% 1M : -8.8% 1Y : -36.7%
COMMUNITY POLL
for JUBILANT PHARMOVA
Please provide your vote to see the results
JUBILANT PHARMOVA is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Industry Peers & Returns1W1M1Y
JUBILANT PHARMOVA -5.6% -8.8% -36.7%
SUN PHARMACEUTICAL INDUSTRIES 0.5% -0.1% 12.5%
DIVIS LABORATORIES -14.3% -19.1% -36.2%
CIPLA 1.4% -4.4% 9%
DR REDDYS LABORATORIES 2.7% 3.5% 2.1%
TORRENT PHARMACEUTICALS 1% -0.4% 14.4%
ABBOTT INDIA 3.8% -4.4% 32%
ZYDUS LIFESCIENCES 9.6% 7% 17.2%
ALKEM LABORATORIES 3.4% 4.1% -12.8%

FUNDAMENTAL ANALYSIS OF JUBILANT PHARMOVA

 
Fundamentals Score
[ Q(TTM): Dec2022, Y: Mar2022
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]


VALUATION OF JUBILANT PHARMOVA

 
Valuation Score
[As on : Feb 08,2023 ]

Ratio Consolidated
P/E
P/B
P/S
53.49
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 97.84 Cr
[Latest Qtr - Dec2022 - Consolidated Results ]

0.98
P/B Calculated based on Book Value of Rs 5,314.90 Cr
[Latest Year - Mar2022 - Consolidated Results ]

0.85
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 6,131.26 Cr
[Latest Qtr - Dec2022 - Consolidated Results ]

Financial Ratios →

Insights 💡 JUBLPHARMA is one of the potential top 29% undervalued companies ! Discover More →

FAIR VALUE OF JUBILANT PHARMOVA

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
-33%
-40%
-38%

Insights 💡 You can learn about various Valuation techniques to calculate Intrinsic Value
with our bestselling video course Value Investing - The Ultimate Guide
Take Me There →

SHARE PRICE MOMENTUM OF JUBILANT PHARMOVA



JUBILANT PHARMOVA vs SENSEX


Insights 💡 You can learn about Basics of Stock Marketing Investing
with our bestselling video course Stock Marketing Investing Simplified
Take Me There →

DEBT OF JUBILANT PHARMOVA

Year Debt/Equity ratio
Standalone Consolidated
2022
2021
2020
Avg_3yrs
0.39
0.38
0.75
0.51
0.55
0.55
0.83
0.64
[Last Annual Data : Mar2022]
Financial Ratios →

PLEDGED PROMOTER SHARES OF JUBILANT PHARMOVA

Pledged Promoter Shares
NA

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad
Shareholding Pattern →

QTRLY RESULTS OF JUBILANT PHARMOVA

Consolidated Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
-2.94%
-33.31%
-73.43%
-289.84%
18.46%
-24.9%
-85.21%
-128.34%
QtrlyTrend
-6
Latest Qtr: Dec2022
Quarterly Result Analysis →


JUBILANT PHARMOVA related INDICES

BSE Indices1W1M1Y
S&P BSE 400 MIDSMALLCAP 1.5% -1.1% -1.6%
S&P BSE MIDSMALLCAP 1.5% -1.6% -3.1%
S&P BSE 500 1.2% -1.7% -0.6%
S&P BSE ALLCAP 1.2% -1.8% -0.8%
S&P BSE 250 SMALLCAP 1.1% -1.4% -6%
NSE Indices1W1M1Y
NIFTY MID SMALL400 1.4% -1.5% -1.8%
NIFTY 500 1.2% -1.6% -0.7%
NIFTY500 MULTICAP 50:25:25 1.2% -1.6% -1.9%
NIFTY SMALLCAP250 0.7% -2% -8.2%

You may also like the below Video Courses


FAQ about JUBILANT PHARMOVA


Is JUBILANT PHARMOVA good for long term investment?

As on Feb 08,2023, the Fundamentals of JUBILANT PHARMOVA look Average and hence you may wait for the results to improve to invest for long term ! See Financial Performance of JUBILANT PHARMOVA . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is JUBILANT PHARMOVA UnderValued or OverValued?

As on Feb 08,2023, JUBILANT PHARMOVA is Under Valued based on the estimates of intrinsic value and hence may be a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of JUBILANT PHARMOVA ?

As on Feb 08,2023, the Intrinsic Value of JUBILANT PHARMOVA is Rs. 531.63 estimated based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 488.30
Fair Value [Median EV / Sales Model] : Rs. 544.46
Fair Value [Median Price / Sales Model] : Rs. 531.63
Estimated Median Fair Value of JUBILANT PHARMOVA : Rs. 531.63

The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.

Is JUBILANT PHARMOVA trading at a Premium or Discount?

As on Feb 08,2023, JUBILANT PHARMOVA is trading at a Discount of -38% based on the estimates of Median Intrinsic Value!

SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].